Tag: SAVE trial

Treatment with a sustained-release sirolimus-eluting balloon (SLR) for patients with failing arteriovenous fistulas (AVFs) was associated with higher target-lesion primary patency (TLPP) through to...

A first report from the SAVE prospective, multicentre, single-blinded randomised controlled trial of the Selution sustained limus release (SLR; Cordis) drug-eluting balloon (DEB) in...